Die Rolle der Quinonoxidoreduktase bei der Progression des neuronalen Zelltodes und Charakterisierung endogener neuroprotektive SystemeUlrike Susanne HarmsEinleitung12Zielstellungen 23Methodik3456Ergebnisse 7891011Diskussion 11121314LiteraturverzeichnisDanksagungEidestattliche ErklärungdeInhaltsverzeichnisHilfe Literaturverzeichnis 1. Kerr,J.F. Shrinkage necrosis: a distinct mode of cellular death. J. Pathol. 105 , 13-20 (1971). 2. Linnik,M.D., Zobrist,R.H. & Hatfield,M.D. Evidence supporting a role for programmed cell death in focal cerebral ischemia in rats. Stroke 24, 2002-2008 (1993). 3. Fink,K. et al. Prolonged therapeutic window for ischemic brain damage caused by delayed caspase activation. J. Cereb. Blood Flow Metab. 18, 1071-1076 (1998). 4. Endres,M. et al. Attenuation of delayed neuronal death after mild focal ischemia in mice by inhibition of the caspase family. J. Cereb. Blood Flow Metab. 18, 238-247 (1998). 5. Ngo,E.O., Nutter,L.M., Sura,T. & Gutierrez,P.L. Induction of p53 by the concerted actions of aziridine and quinone moieties of diaziquone. Chem. Res. Toxicol. 11, 360-368 (1998). 6. Pink,J.J. et al. NAD(P)H:Quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity. J. Biol. Chem. 275, 5416-5424 (2000). 7. Asher,G., Lotem,J., Cohen,B., Sachs,L. & Shaul,Y. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc. Natl. Acad. Sci. U. S. A 98, 1188-1193 (2001). 8. Paganini-Hill,A. & Henderson,V.W. Estrogen deficiency and risk of Alzheimer's disease in women. Am. J. Epidemiol. 140, 256-261 (1994). 9. Robinson,D., Friedman,L., Marcus,R., Tinklenberg,J. & Yesavage,J. Estrogen replacement therapy and memory in older women. J. Am. Geriatr. Soc. 42, 919-922 (1994). 10. Hurn,P.D. & Macrae,I.M. Estrogen as a neuroprotectant in stroke. J. Cereb. Blood Flow Metab. 20, 631-652 (2000). 11. Allison,D.W., Gelfand,V.I., Spector,I. & Craig,A.M. Role of actin in anchoring postsynaptic receptors in cultured hippocampal neurons: differential attachment of NMDA versus AMPA receptors. J. Neurosci. 18, 2423-2436 (1998). 12. Furukawa,K. et al. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J. Neurosci. 17, 8178-8186 (1997). 13. Endres,M. et al. Neuroprotective effects of gelsolin during murine stroke. J. Clin. Invest 103, 347-354 (1999). 14. Brewer,G.J. Serum-free B27/neurobasal medium supports differentiated growth of neurons from the striatum, substantia nigra, septum, cerebral cortex, cerebellum, and dentate gyrus. J. Neurosci. Res. 42, 674-683 (1995). 15. Harms,C. et al. Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures. FASEB J. 14, 1814-1824 (2000). 16. Murphy,T.H., De,L.M. & Coyle,J.T. Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress. J. Neurochem. 56, 990-995 (1991). 17. Kwiatkowski,D.J. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr. Opin. Cell Biol. 11, 103-108 (1999). 18. Bubb,M.R., Senderowicz,A.M., Sausville,E.A., Duncan,K.L. & Korn,E.D. Jasplakinolide, a cytotoxic natural product, induces actin polymerization and competitively inhibits the binding of phalloidin to F-actin. J. Biol. Chem. 269, 14869-14871 (1994). 19. Koh,J.Y. & Choi,D.W. Quantitative determination of glutamate mediated cortical neuronal injury in cell culture by lactate dehydrogenase efflux assay. J. Neurosci. Methods 20, 83-90 (1987). 20. Prochaska,H.J. & Santamaria,A.B. Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtiter wells: a screening assay for anticarcinogenic enzyme inducers. Anal. Biochem. 169, 328-336 (1988). 21. Murphy,T.H., So,A.P. & Vincent,S.R. Histochemical detection of quinone reductase activity in situ using LY 83583 reduction and oxidation. J. Neurochem. 70, 2156-2164 (1998). 22. Swanson,R.A. et al. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10, 290-293 (1990). 23. Harms,C. et al. Differential mechanisms of neuroprotection by 17 beta-estradiol in apoptotic versus necrotic neurodegeneration. J. Neurosci. 21, 2600-2609 (2001). 24. Kapinya,K.J. et al. Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischaemia in vivo. J. Neurochem. 84, 1028-1039 (2003). 25. Harms,C. et al. Neuronal gelsolin prevents apoptosis by enhancing actin depolymerization. Mol. Cell Neurosci. 25, 69-82 (2004). 26. Raina,A.K., Templeton,D.J., Deak,J.C., Perry,G. & Smith,M.A. Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease. Redox. Rep. 4, 23-27 (1999). 27. Wang,Y., Santa-Cruz,K., DeCarli,C. & Johnson,J.A. NAD(P)H:quinone oxidoreductase activity is increased in hippocampal pyramidal neurons of patients with Aalzheimer's disease. Neurobiol. Aging 21, 525-531 (2000). 28. Laxton,A.W., Sun,M.C., Shen,H., Murphy,T.H. & Honey,C.R. The antioxidant enzyme quinone reductase is up-regulated in vivo following cerebral ischemia. Neuroreport. 12, 1045-1048 (2001). 29. Gottron,F.J., Ying,H.S. & Choi,D.W. Caspase inhibition selectively reduces the apoptotic component of oxygen-glucose deprivation-induced cortical neuronal cell death. Mol. Cell Neurosci. 9, 159-169 (1997). 30. Murphy,T.H. et al. Preferential expression of antioxidant response element mediated gene expression in astrocytes. J. Neurochem. 76, 1670-1678 (2001). 31. Duffy,S., So,A. & Murphy,T.H. Activation of endogenous antioxidant defenses in neuronal cells prevents free radical-mediated damage. J. Neurochem. 71, 69-77 (1998). 32. Moehlenkamp,J.D. & Johnson,J.A. Activation of antioxidant/electrophile-responsive elements in IMR-32 human neuroblastoma cells. Arch. Biochem. Biophys. 363, 98-106 (1999). 33. Dinkova-Kostova,A.T. & Talalay,P. Persuasive evidence that quinone reductase type 1 (DT diaphorase) protects cells against the toxicity of electrophiles and reactive forms of oxygen. Free Radic. Biol. Med. 29, 231-240 (2000). 34. Li,Y. & Jaiswal,A.K. Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J. Biol. Chem. 268, 21454 (1993). 35. Prestera,T., Zhang,Y., Spencer,S.R., Wilczak,C.A. & Talalay,P. The electrophile counterattack response: protection against neoplasia and toxicity. Adv. Enzyme Regul. 33, 281-296 (1993). 36. Valerio,L.G.J., Kepa,J.K., Pickwell,G.V. & Quattrochi,L.C. Induction of human NAD(P)H:quinone oxidoreductase (NQO1) gene expression by the flavonol quercetin. Toxicol. Lett. 119, 49-57 (2001). 37. Ahlgren-Beckendorf,J.A., Reising,A.M., Schander,M.A., Herdler,J.W. & Johnson,J.A. Coordinate regulation of NAD(P)H:quinone oxidoreductase and glutathione-S-transferases in primary cultures of rat neurons and glia: role of the antioxidant/electrophile responsive element. Glia 25, 131-142 (1999). 38. Iwata-Ichikawa,E., Kondo,Y., Miyazaki,I., Asanuma,M. & Ogawa,N. Glial cells protect neurons against oxidative stress via transcriptional up-regulation of the glutathione synthesis. J. Neurochem. 72, 2334-2344 (1999). 39. Campagne,M.V., Thibodeaux,H., van,B.N., Cairns,B. & Lowe,D.G. Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion. J. Neurosci. 20, 5200-5207 (2000). 40. Eftekharpour,E., Holmgren,A. & Juurlink,B.H. Thioredoxin reductase and glutathione synthesis is upregulated by t-butylhydroquinone in cortical astrocytes but not in cortical neurons. Glia 31, 241-248 (2000). 41. Hoult,J.R. & Paya,M. Pharmacological and biochemical actions of simple coumarins: natural products with therapeutic potential. Gen. Pharmacol. 27, 713-722 (1996). 42. Planchon,S.M. et al. beta-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3. Exp. Cell Res. 267, 95-106 (2001). 43. Siemankowski,L.M., Morreale,J., Butts,B.D. & Briehl,M.M. Increased tumor necrosis factor-alpha sensitivity of MCF-7 cells transfected with NAD(P)H:quinone reductase. Cancer Res. 60, 3638-3644 (2000). 44. Crumrine,R.C., Thomas,A.L. & Morgan,P.F. Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J. Cereb. Blood Flow Metab. 14, 887-891 (1994). 45. Banasiak,K.J. & Haddad,G.G. Hypoxia-induced apoptosis: effect of hypoxic severity and role of p53 in neuronal cell death. Brain Res. 797, 295-304 (1998). 46. Culmsee,C. et al. A synthetic inhibitor of p53 protects neurons against death induced by ischemic and excitotoxic insults, and amyloid beta-peptide. J. Neurochem. 77, 220-228 (2001). 47. Dubal,D.B. et al. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc. Natl. Acad. Sci. U. S. A98, 1952-1957 (2001). 48. Kahlert,S. et al. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J. Biol. Chem. 275, 18447-18453 (2000). 49. Kothakota,S. et al. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science 278, 294-298 (1997). 50. Azuma,T., Koths,K., Flanagan,L. & Kwiatkowski,D. Gelsolin in complex with phosphatidylinositol 4,5-bisphosphate inhibits caspase-3 and -9 to retard apoptotic progression. J. Biol. Chem. 275, 3761-3766 (2000). 51. Koya,R.C. et al. Gelsolin inhibits apoptosis by blocking mitochondrial membrane potential loss and cytochrome c release. J. Biol. Chem. 275, 15343-15349 (2000).